Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Sopan Nangare & Pravin Patil. (2022) Nanoarchitectured Bioconjugates and Bioreceptors Mediated Surface Plasmon Resonance Biosensor for In Vitro Diagnosis of Alzheimer’s Disease: Development and Future Prospects. Critical Reviews in Analytical Chemistry 52:5, pages 1139-1169.
Read now
Read now
Harald Hampel, Andrea Vergallo, Mohammad Afshar, Leyla Akman-Anderson, Joaquín Arenas, Norbert Benda, Richard Batrla, Karl Broich, Filippo Caraci, A. Claudio Cuello, Enzo Emanuele, Marion Haberkamp, Steven J. Kiddle, Alejandro Lucía, Mark Mapstone, Steven R. Verdooner, Janet Woodcock & Simone Lista. (2019) Blood-based systems biology biomarkers for
next-generation clinical trials in Alzheimer’s disease
. Dialogues in Clinical Neuroscience 21:2, pages 177-191.
Read now
Read now
Articles from other publishers (23)
Shital Rani, Sudhrita Basu Dhar, Akhil Khajuria, Dikshi Gupta, Pradeep Kumar Jaiswal, Neha Singla, Mandeep Kaur, Gurpal Singh & Ravi Pratap Barnwal. (2023) Advanced Overview of Biomarkers and Techniques for Early Diagnosis of Alzheimer’s Disease. Cellular and Molecular Neurobiology 43:6, pages 2491-2523.
Crossref
Crossref
Taís C. Ribeiro, Rafael M. Sábio, Gabriela C. Carvalho, Bruno Fonseca-Santos & Marlus Chorilli. (2022) Exploiting mesoporous silica, silver and gold nanoparticles for neurodegenerative diseases treatment. International Journal of Pharmaceutics 624, pages 121978.
Crossref
Crossref
Phoebe Imms, Helena C. Chui & Andrei Irimia. (2022) Alzheimer’s disease after mild traumatic brain injury. Aging 14:13, pages 5292-5293.
Crossref
Crossref
Rahul Ghosal, Vijay R. Varma, Dmitri Volfson, Jacek Urbanek, Jeffrey M. Hausdorff, Amber Watts & Vadim Zipunnikov. (2022) Scalar on time-by-distribution regression and its application for modelling associations between daily-living physical activity and cognitive functions in Alzheimer’s Disease. Scientific Reports 12:1.
Crossref
Crossref
Fabiha Zaheen Khan, Md Shaki Mostaid & Mohd Nazmul Hasan Apu. (2022) Molecular signaling pathway targeted therapeutic potential of thymoquinone in Alzheimer’s disease. Heliyon 8:7, pages e09874.
Crossref
Crossref
Gábor Ternák, Márton Németh, Martin Rozanovic & Lajos Bogár. (2022) Alzheimer’s Disease-Related Dysbiosis Might Be Triggered by Certain Classes of Antibiotics with Time-Lapse: New Insights into the Pathogenesis?. Journal of Alzheimer's Disease 87:1, pages 443-451.
Crossref
Crossref
Bouvourné Parfait, Beppe Galba Jean, Ponka Roger, Ngatanko Abaissou Hervé Hervé, Kamleu Kwingwa Balbine, Camdi Woumitna Guillaume, Guedang Nyayi Simon Desire, Damo Kamda Jorelle Linda, Kenko Djoumessie Léa Blondelle & Sotoing Taiwe Germain. (2022) Antioxidant and Anticholinesterase Properties of the Aqueous Extract of Balanites aegyptiaca L. Delile Fruit Pulp on Monosodium Glutamate-Induced Excitotoxicity in Swiss Mice. Evidence-Based Complementary and Alternative Medicine 2022, pages 1-15.
Crossref
Crossref
K. Mahalakshmi, D. Parimalanandhini, R. Sangeetha, M. Livya Catherene, M. Beulaja, R. Thiagarajan, M. Arumugam, S. Janarthanan & R. Manikandan. (2021) Influential role of 7-Ketocholesterol in the progression of Alzheimer’s disease. Prostaglandins & Other Lipid Mediators 156, pages 106582.
Crossref
Crossref
J. L. Liss, S. Seleri Assunção, J. Cummings, A. Atri, D. S. Geldmacher, S. F. Candela, D. P. Devanand, H. M. Fillit, J. Susman, J. Mintzer, T. Bittner, S. A. Brunton, D. R. Kerwin, W. C. Jackson, G. W. Small, G. T. Grossberg, C. K. Clevenger, V. Cotter, R. Stefanacci, A. Wise‐Brown & M. N. Sabbagh. (2021) Practical recommendations for timely, accurate diagnosis of symptomatic Alzheimer’s disease (MCI and dementia) in primary care: a review and synthesis. Journal of Internal Medicine 290:2, pages 310-334.
Crossref
Crossref
Anis Davoudi, Catherine Dion, Shawna Amini, Patrick J. Tighe, Catherine C. Price, David J. Libon & Parisa Rashidi. (2021) Classifying Non-Dementia and Alzheimer’s Disease/Vascular Dementia Patients Using Kinematic, Time-Based, and Visuospatial Parameters: The Digital Clock Drawing Test. Journal of Alzheimer's Disease 82:1, pages 47-57.
Crossref
Crossref
Ryuji Yamazaki, Shuichi Nishio, Kazue Shigenobu, Elie Maalouly & Hiroshi Ishiguro. (2021) Estimation of Dementia Severity Using SVM based on Patient's Engagement Levels in Conversation. Estimation of Dementia Severity Using SVM based on Patient's Engagement Levels in Conversation.
Taeksu Kim, Seong In Chi, Hyuk Kim & Kwang-Suk Seo. (2021) Analysis of behavioral management for dental treatment in patients with dementia using the Korean National Health Insurance data. Journal of Dental Anesthesia and Pain Medicine 21:5, pages 461.
Crossref
Crossref
Fatma Tugce Guragac Dereli & Tarun Belwal. 2021. Naturally Occurring Chemicals Against Alzheimer's Disease. Naturally Occurring Chemicals Against Alzheimer's Disease
109
115
.
Ram Sagar, Pujita Pathak, Balint Pandur, Sujung Jun Kim, Jiaxin Li & Vasiliki Mahairaki. 2021. GeNeDis 2020. GeNeDis 2020
403
408
.
Vijay R. Varma, Rahul Ghosal, Inbar Hillel, Dmitri Volfson, Jordan Weiss, Jacek Urbanek, Jeffrey M. Hausdorff, Vadim Zipunnikov & Amber Watts. (2021) Continuous gait monitoring discriminates community‐dwelling mild Alzheimer's disease from cognitively normal controls. Alzheimer's & Dementia: Translational Research & Clinical Interventions 7:1.
Crossref
Crossref
Harminder Singh, Viney Chawla, Ritu Bala & Harish Dureja. (2020) Current and Future of Alzheimer's Therapy with the Best Approach. CNS & Neurological Disorders - Drug Targets 19:9, pages 691-697.
Crossref
Crossref
Daichi Shigemizu, Taiki Mori, Shintaro Akiyama, Sayuri Higaki, Hiroshi Watanabe, Takashi Sakurai, Shumpei Niida & Kouichi Ozaki. (2020) Identification of potential blood biomarkers for early diagnosis of Alzheimer’s disease through RNA sequencing analysis. Alzheimer's Research & Therapy 12:1.
Crossref
Crossref
Andrei Irimia, Alexander S. Maher, Nikhil N. Chaudhari, Nahian F. Chowdhury & Elliot B. Jacobs. (2020) Acute cognitive deficits after traumatic brain injury predict Alzheimer’s disease-like degradation of the human default mode network. GeroScience 42:5, pages 1411-1429.
Crossref
Crossref
Makrina Karaglani, Krystallia Gourlia, Ioannis Tsamardinos & Ekaterini Chatzaki. (2020) Accurate Blood-Based Diagnostic Biosignatures for Alzheimer’s Disease via Automated Machine Learning. Journal of Clinical Medicine 9:9, pages 3016.
Crossref
Crossref
Valentina Carlini, Ivan Verduci, Francesca Cianci, Gaetano Cannavale, Chiara Fenoglio, Daniela Galimberti & Michele Mazzanti. (2020) CLIC1 Protein Accumulates in Circulating Monocyte Membrane during Neurodegeneration. International Journal of Molecular Sciences 21:4, pages 1484.
Crossref
Crossref
Martina Zvěřová. (2019) News in gerontopsychiatry. Psychiatrie pro praxi 20:3, pages 108-110.
Crossref
Crossref
Martina Zvěřová. (2019) Clinical aspects of Alzheimer's disease. Clinical Biochemistry 72, pages 3-6.
Crossref
Crossref
Jana Janssens, Sawal D. Atmosoerodjo, Yannick Vermeiren, Anthony R. Absalom, Izaak den Daas & Peter P. De Deyn. (2019) Sampling issues of cerebrospinal fluid and plasma monoamines: Investigation of the circadian rhythm and rostrocaudal concentration gradient. Neurochemistry International 128, pages 154-162.
Crossref
Crossref